Customize your JAMA Network experience by selecting one or more topics from the list below.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Shah R, Kuo Y, Westra J, Lin Y, Raji MA. Opioid Use and Pain Control After Total Hip and Knee Arthroplasty in the US, 2014 to 2017. JAMA Netw Open. 2020;3(7):e2011972. doi:10.1001/jamanetworkopen.2020.11972
Potential overprescribing of opioids after surgery may contribute to opioid-related adverse events.1,2 The proportion of opioid-naive patients with a new opioid prescription within 7 days after total knee arthroplasty (TKA) increased from 79.1% in 2004 to 82.0% in 2012.3 The US Drug Enforcement Administration in 2014,4 the US Centers for Disease Control and Prevention in 2016,5 and health systems, state governments, and health payers all implemented myriad policies to restrict opioid overprescribing. The impact of these policies on postoperative opioid prescribing is unknown. We examined rates of opioid prescribing and level of pain control in patients who underwent total hip arthroplasty (THA) and TKA from 2014 to 2017.
Create a personal account or sign in to: